Polychlorinated biphenyls alter the expression of endothelial nitric oxide synthase mRNA in human umbilical vein endothelial cells

Human and Experimental Toxicology

Volumn 26, Issue 10, 2007, Pages 811-816

  Omori, Naoko ^a   Fukata, Hideki ^a   Sato, Koji ^a   Yamazaki, Koji ^a   Aida Yasuoka, Keiko ^a   Takigami, Hidetaka ^b   Kuriyama, Motone ^a   Ichinose, Masaharu ^a   Mori, Chisato ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

Aryl hydrocarbon receptor (AhR); Endothelial nitric oxide synthase (eNOS); Estrogen receptors (ERs); Human umbilical vein endothelial cells (HUVECs); Polychlorinated biphenyls (PCBs)

Indexed keywords

2,2',4,4',5,5' HEXACHLOROBIPHENYL; 3,3',4,4' TETRACHLOROBIPHENYL; 3,3',4,4',5 PENTACHLOROBIPHENYL; ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FETUS CIRCULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN;

BENZOFLAVONES; CELLS, CULTURED; CYTOCHROME P-450 CYP1A1; ENDOTHELIAL CELLS; ESTRADIOL; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; POLYCHLORINATED BIPHENYLS; RECEPTORS, CHOLINERGIC; RNA, MESSENGER; UMBILICAL VEINS;

EID: 36849064721     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327107072394     Document Type: Article

References (27)

1. Fischer LJ, Wagner MA, Madhukar BV. Potential involvement of calcium, CaM kinase II, and MAP kinases in PCB-stimulated insulin release from RINm5F cells. Toxicol Appl Pharmacol 1999; 159: 194-203.
2. Sharma R, Kodavanti PR. In vitro effects of polychlorinated biphenyls and hydroxy metabolites on nitric oxide synthases in rat brain. Toxicol Appl Pharmacol 2002; 178: 127-36.
3. Segre M, Arena SM, Greeley EH, Melancon MJ, Graham DA, French JB, Jr. Immunological and physiological effects of chronic exposure of Peromyscus leucopus to Aroclor 1254 at a concentration similar to that found at contaminated sites. Toxicology 2002; 174: 163-72.
4. Kuriyama SN, Chahoud I. In utero exposure to low-dose 2,3′,4,4′,5-pentachlorobiphenyl (PCB 118) impairs male fertility and alters neurobehavior in rat offspring. Toxicology 2004; 202: 185-97.
5. Todaka E, Mori C. Necessity to establish new risk assessment and risk communication for human fetal exposure to multiple endocrine disruptors in Japan. Congenit Anom (Kyoto) 2002; 42: 87-93.
6. Mori C, Komiyama M, Adachi T, Sakurai K, Nishimura D, Takashima K, Todaka E. Application of toxicogenomic analysis to risk assessment of delayed long-term effects of multiple chemicals, including endocrine disruptors in human fetuses. EHP Toxicogenomics 2003; 111: 7-13.
7. Fukata H, Omori M, Osada H, Todaka E, Mori C. Necessity to measure PCBs and organochlorine pesticide concentrations in human umbilical cords for fetal exposure assessment. Environ Health Perspect 2005; 113: 297-303.
8. Shepherd JT, Katusic ZS. Endothelium-derived vasoactive factors: I. Endothelium-dependent relaxation. Hypertension 1991; 18: III76-85.
9. Boura AL, Walters WA, Read MA, Leitch IM. Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol 1994; 21: 737-48.
10. Li H, Wallerath T, Forstermann U. Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 2002; 7: 132-47.
11. Li H, Wallerath T, Munzel T, Forstermann U. Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 2002; 7: 149-64.
12. Vasquez G, Sanhueza F, Vasquez R, Gonzalez M, San Martin R, Casanello P, Sobrevia L. Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J Physiol 2004; 560: 111-22.
13. Casanello P, Sobrevia L. Intrauterine growth retardation is associated with reduced activity and expression of the cationic amino acid transport systems y+/hCAT-1 and y+/hCAT-2B and lower activity of nitric oxide synthase in human umbilical vein endothelial cells. Circ Res 2002; 91: 127-34.
14. Van den Berg M, Birnbaum L, Bosveld AT, Brunstrom B, Cook P, Feeley M, Giesy JP, Hanberg A, Hasegawa R, Kennedy SW, Kubiak T, Larsen JC, van Leeuwen FX, Liem AK, Nolt C, Peterson RE, Poellinger L, Safe S, Schrenk D, Tillitt D, Tysklind M, Younes M, Waern F, Zacharewski T. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 1998; 106: 775-92.
15. Vondracek J, Machala M, Bryja V, Chramostova K, Krcmar P, Dietrich C, Hampl A, Kozubik A. Aryl hydrocarbon receptor-activating polychlorinated biphenyls and their hydroxylated metabolites induce cell proliferation in contact-inhibited rat liver epithelial cells. Toxicol Sci 2005; 83: 53-63.
16. Suh J, Kang JS, Yang KH, Kaminski NE. Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-orthosubstituted polychlorinated biphenyls. Toxicol Appl Pharmacol 2003; 187: 11-21.
17. Hansen LG. Stepping backward to improve assessment of PCB congener toxicities. Environ Health Perspect 1998; 106 Suppl 1: 171-89.
18. Pollenz RS, Sattler CA, Poland A. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol Pharmacol 1994; 45: 428-38.
19. Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 1995; 35: 307-40.
20. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J, Chambon P, Yanagisawa J, Fujii-Kuriyama Y, Kato S. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 2003; 423: 545-50.
21. Nuedling S, Karas RH, Mendelsohn ME, Katzenellenbogen JA, Katzenellenbogen BS, Meyer R, Vetter H, Grohe C. Activation of estrogen receptor beta is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes. FEBS Lett 2001; 502: 103-8.
22. Kakui K, Itoh H, Sagawa N, Yura S, Korita D, Takemura M, Miyamaoto Y, Saito Y, Nakao K, Fujii S. Augmented endothelial nitric oxide synthase (eNOS) protein expression in human pregnant myometrium: possible involvement of eNOS promoter activation by estrogen via both estrogen receptor (ER)alpha and ERbeta. Mol Hum Beprod 2004; 10: 115-22.
23. Tan E, Gurjar MV, Sharma RV, Bhalla RC. Estrogen receptor-alpha gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration. Cardiovasc Res 1999; 43: 788-97.
24. Hennig B, Meerarani P, Slim R, Toborek M, Daugherty A, Silverstone AE, Robertson LW. Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol Appl Pharmacol 2002; 181: 174-83.
25. Chen G, Bunce NJ. Interaction between halogenated aromatic compounds in the Ah receptor signal transduction pathway. Environ Toxicol 2004; 19: 480-89.
26. Tavolari S, Bucci L, Tomasi V, Guarnieri T. Selected polychlorobiphenyls congeners bind to estrogen receptor alpha in human umbilical vascular endothelial (HUVE) cells modulating angiogenesis. Toxicology 2006; 218: 67-74.
27. Abdelrahim M, Ariazi E, Kim K, Khan S, Barhoumi R, Burghardt R, Liu S, Hill D, Finnell R, Wlodarczyk B, Jordan VC, Safe S. 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha. Cancer Res 2006; 66: 2459-67.